DEA and HHS extend virtual prescribing for controlled substances through 2025
The third extension of pandemic-era telehealth flexibilities through the end of next year will give the agencies time to promulgate final regulations and providers time to comply, the agencies said.
The third extension of pandemic-era telehealth flexibilities through the end of next year will give the agencies time to promulgate final regulations and providers time to comply, the agencies said.
Go to Source
2024-11-18 21:04
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
